Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SciBrunch Therapeutics is a Shanghai-based biotechnology company focused on discovering and developing innovative small molecule anti-tumor drugs to address unmet needs in cancer treatment. With a research-driven approach and strategic early-stage pipeline, SciBrunch aims to advance novel oncology therapies through preclinical and clinical development, leveraging scientific excellence to improve outcomes for patients facing di...
SciBrunch Therapeutics is a Shanghai-based biotechnology company focused on discovering and developing innovative small molecule anti-tumor drugs to address unmet needs in cancer treatment. With a research-driven approach and strategic early-stage pipeline, SciBrunch aims to advance novel oncology therapies through preclinical and clinical development, leveraging scientific excellence to improve outcomes for patients facing difficult-to-treat cancers.

List your booth number for exhibitions, ask us